We've found
9,220
archived clinical trials in
HIV / AIDS
We've found
9,220
archived clinical trials in
HIV / AIDS
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Optimizing Treatment for Treatment-Experienced, HIV-Infected People
Updated: 12/8/2015
The Optimized Treatment That Includes or Omits NRTIs Trial: A Randomized Strategy Study for HIV-1-Infected Treatment-Experienced Subjects Using the cPSS to Select an Effective Regimen
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Assessing the Safety of Dapivirine Gel and Film Formulations
Status: Enrolling
Updated: 12/8/2015
Updated: 12/8/2015
Assessing the Safety of Dapivirine Gel and Film Formulations
Status: Enrolling
Updated: 12/8/2015
Updated: 12/8/2015
Click here to add this to my saved trials
Randomized Control Trial of Family-Based HIV Prevention for Latinos
Updated: 12/8/2015
A Randomized Controlled Trial of Family-Based HIV Prevention for Latino Youth
Status: Enrolling
Updated: 12/8/2015
Randomized Control Trial of Family-Based HIV Prevention for Latinos
Updated: 12/8/2015
A Randomized Controlled Trial of Family-Based HIV Prevention for Latino Youth
Status: Enrolling
Updated: 12/8/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Updated: 12/9/2015
Cardiovascular, Anthropometric, and Skeletal Effects of Antiretroviral Therapy (ART) Initiation With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Plus Atazanavir/Ritonavir (ATV/r), Darunavir/Ritonavir (DRV/r), or Raltegravir (RAL): Metabolic Substudy of A5257
Status: Enrolling
Updated: 12/9/2015
Click here to add this to my saved trials